Propentofylline in the Treatment of Alzheimer’s Disease and Vascular Dementia: A Review of Phase III Trials

Publisher： Karger

E-ISSN： 1421-9824|9|1|36-43

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.9, Iss.1, 1998-07, pp. : 36-43

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pathogenic Factors in Vascular Dementia and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 18, Iss. 3-4, 2004-10 ,pp. : 278-298

Karger

Access to resources Recommend Favorite

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-01 ,pp. : 31-42

Karger

Access to resources Recommend Favorite

Frontal Impairment in Subcortical Ischemic Vascular Dementia in Comparison to Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 13, Iss. 2, 2002-02 ,pp. : 101-111

Karger

Access to resources Recommend Favorite

Neuropsychological Deficit in Early Subcortical Vascular Dementia: Comparison to Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 14, Iss. 1, 2002-06 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

In vivo Quantification of Brain Volumes in Subcortical Vascular Dementia and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 9, Iss. 6, 1998-10 ,pp. : 309-316

Karger

Access to resources Recommend Favorite